Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Malaria
Noze nabs $1M grant from Bill & Melinda Gates Foundation to develop breath testing platform
The aim is to develop a platform that enables rapid screening and diagnostic testing for infectious diseases such as malaria and tuberculosis that impact millions of people, particularly in developing countries, Noze said.
March 14, 2023
Device automates blood smears for malaria diagnosis
Malaria is typically diagnosed by analyzing blood smears through a microscope. The devices, called the autohaem smear and autohaem smear+, can consistently create high-quality smears equivalent to those created by human experts.
January 17, 2022
MilliporeSigma secures $137M contract from U.S. government
The award will cover a three-year period and is from the U.S. Department of Defense, on behalf of the U.S. Department of Health and Human Services; it is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness, the company said in a press release.
January 3, 2022
Sysmex introduces automated analyzer for malaria detection
The company said Plasmodium falciparum from nonfalciparum species are differentiated by the analyzer. The system can also determine the life cycle staging of the parasites detected.
September 30, 2021
MicroRNA blood test identifies severe malaria in children
The plasma test screens for miRNAs released by human brain endothelial cells that are associated with damage to organs, such as the lungs, kidney, or brain, caused by the sequestration of red blood cells infected with Plasmodium falciparum.
January 12, 2021
Researchers validate antibody test for malaria, try similar approach for COVID-19
In the article, investigators shared their experience with the development and evaluation of a panel of serological markers to measure antibody responses to liver-stage parasites, or hypnozoites, which are found in people with malaria caused by Plasmodium vivax. This type of malaria is known to lie dormant, noted an international research team from the Walter and Eliza Hall Institute of Medical Research in Australia, the Pasteur Institute in France, and Ehime University in Japan.
May 17, 2020
Most Popular
Quest launches long-COVID testing panels for consumers
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
FDA grants 510(k) clearance to DiaSorin for COVID-19 and flu A/B assay
LumiraDx Q4 revenues drop 65% on lower COVID-19 testing
Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux
New field test for malaria drug resistance on horizon
Co-lead investigator Mindy Leelawong, PhD, and colleagues reported that they have validated a point-of-care platform for a field-deployable PCR instrument, based on a study showing the test can differentiate between the wild-type form of the malaria-causing parasite Plasmodium falciparum and mutant types that are resistant to chloroquine, an older treatment for the disease.
June 12, 2019
Sysmex gets CE Mark for XN-31 hematology analyzer
XN-31 offers hematology parameters typically used for blood testing, but it can also determine via automatic measurement in about one minute whether red blood cells are infected by malaria parasites. Current malaria testing is performed using microscopes or rapid diagnostic tests, the company noted.
April 25, 2019
Page 1 of 1
